资本家对科学家的要求还是比较苛刻的查看图片
$Arvinas(ARVN)$ 结果不及预期
#ASCO2020#
Background:
Proteolysis Targeting Chimera (PROTAC) protein degraders induce selective degradation of targeted proteins by engaging the ubiquitin proteasome system. ARV-110 is an orally bioavailable PROTAC that specifically ...